Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety.
Borsari C, Rageot D, Beaufils F, Bohnacker T, Keles E, Buslov I, Melone A, Sele AM, Hebeisen P, Fabbro D, Hillmann P, Wymann MP.
Borsari C, et al. Among authors: buslov i.
ACS Med Chem Lett. 2019 Sep 3;10(10):1473-1479. doi: 10.1021/acsmedchemlett.9b00333. eCollection 2019 Oct 10.
ACS Med Chem Lett. 2019.
PMID: 31620236
Free PMC article.